Compound ID | 2874
R327 (RECCE 327)
Class: Membrane-active agent
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Membrane-active agent. Disrupts ATP synthesis |
| Target Pathogen: | Active against multi-drug resistant and -susceptible Gram-positives and Gram-negatives |
| Description: | Synthetic polymer; topical and intravenous application |
| Institute where first reported: | Recce |
| Year first mentioned: | 2023 |
| Highest development stage: | Phase 1/Phase 2 (ACTRN12623000056695; ACTRN12623000448640; ACTRN12621001313820) |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.